Detalhe da pesquisa
1.
Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy.
Ann Surg
; 256(2): 334-41, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580946
2.
Lymph node metastases in diffuse malignant peritoneal mesothelioma.
Ann Surg Oncol
; 17(1): 45-53, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19856030
3.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in a patient with peritoneal mesothelioma and HIV infection.
Tumori
; 96(2): 340-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20572597
4.
Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Ann Surg
; 249(2): 243-9, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19212177
5.
Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies.
J Surg Oncol
; 100(4): 321-8, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19697439
6.
Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.
In Vivo
; 23(1): 187-90, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19368148
7.
Colobronchial fistula: an unusual complication after peritonectomy and hyperthermic intra-peritoneal chemotherapy (HIPEC).
In Vivo
; 23(1): 151-3, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19368141
8.
Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Ann Surg Oncol
; 15(2): 526-34, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18043976
9.
Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol
; 14(12): 3443-52, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909918
10.
Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
In Vivo
; 20(6A): 773-6, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17203766
11.
Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
World J Gastrointest Oncol
; 2(1): 36-43, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160815
12.
Pathophysiology and biology of peritoneal carcinomatosis.
World J Gastrointest Oncol
; 2(1): 12-8, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160812
13.
Experience with peritoneal mesothelioma at the Milan National Cancer Institute.
World J Gastrointest Oncol
; 2(2): 76-84, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160925
14.
Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol
; 14(8): 2300-8, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17510772
15.
Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Ann Surg Oncol
; 14(2): 500-8, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17151789
16.
Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Ann Surg Oncol
; 14(9): 2550-8, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17558537